The pattern no single source sees
← Markets
Markets

ASP Isotopes takes 15.1% of ENDRA Life Sciences ahead of a merger that would give it 98.9% of the votes

SEC filings show ASP Isotopes' subsidiary LHE LNG Holdings intends to exercise warrants so it can vote ENDRA shares at a special meeting.

·11 October 2026·2 min read
Stock certificate, merger document, atom symbol, and voting ballot arranged together
Loro collage · props AI-generated

ASP Isotopes reports 15.1% of ENDRA Life Sciences and is expected to hold about 98.9% of the votes once ENDRA merges with Noble Africa and becomes 4K Resources Inc.

Stake
254,015 shares (15.1%)
Purchase price
About $3.8 million
Class B shares due to ASP Isotopes
58,554,185
Expected voting power
About 98.9%
Filing
Schedule 13D, 8 October 2026

ASP Isotopes Inc. (CIK 1921865) and its wholly owned subsidiary LHE LNG Holdings LLC report beneficial ownership of 15.1% of ENDRA Life Sciences Inc. (CIK 1681682), in a Schedule 13D filed with the SEC on 8 October 2026.

The 254,015 shares comprise 66,846 held directly and 187,169 issuable on exercise of pre-funded warrants, calculated on 1,499,912 shares outstanding at 6 October 2026. The figure excludes 324,372 pre-funded warrant shares and 1,156,774 common warrant shares that cannot be exercised until stockholders approve. (Schedule 13D, Item 5, 8 October 2026)

LHE LNG bought the stock and warrants under a securities purchase agreement dated 27 May 2026 for about $3.8 million, paid from cash on hand. (Schedule 13D, Item 3, 8 October 2026)

The filing states that LHE LNG intends to exercise the 187,169 pre-funded warrants before the record date for a special meeting, so that it can vote the shares. (Schedule 13D, Item 4, 8 October 2026)

Under a merger agreement dated 25 June 2026 between ASP Isotopes, Noble Africa LLC, Renergen Limited, ENDRA and a merger subsidiary, Noble Africa would become a wholly owned subsidiary of ENDRA, which would be renamed 4K Resources Inc. ASP Isotopes is entitled to receive 58,554,185 Class B shares carrying ten votes each and is expected to hold about 98.9% of the combined voting power. (Schedule 13D, Item 6, 8 October 2026)

A side letter gives LHE LNG one board observer seat at ENDRA and requires ENDRA to keep cash at least equal to the purchase price in a segregated account. If ENDRA decides not to pursue a definitive agreement for a specified strategic alternative, it must pay LHE LNG the purchase price less the fair market value of the securities. (Schedule 13D, Item 6, 8 October 2026)

The filings do not state the date of the special meeting or when the merger is expected to complete. Loro has made no approach to the company. Figures are as reported in ASP Isotopes' SEC filings.

Primary sources

1 record

Every factual claim above is drawn from these records. Each link resolves to the publisher’s own copy.

U.S. Securities and Exchange Commission
  1. Schedule 13D: ASP Isotopes Inc. / ENDRA Life Sciences Inc. (CIK 1681682)8 Oct 2026·0001477932-26-006128
asp isotopesendra life sciencesschedule 13dlhe lng holdingsmerger agreementrenergennoble africa
The Loro newsletter

The week’s stories from the public record

What the registers and filings showed this week, the stories Loro found in them, and the numbers behind each one. Starts in the new year; register now to get it from the first issue.

We will email you to confirm your address, then send the Loro newsletter when it starts. We do not sell or share your data. Unsubscribe at any time. How we handle it.